Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mustafa Khasraw

Showing results (91-100 of 176) with videos related to

Pageof 18
Sort By:
Plos One|February 15, 2019
Tailored NEOadjuvant epirubicin, cyclophosphamide and Nanoparticle Albumin-Bound paclitaxel for breast cancer: The phase II NEONAB trial-Clinical outcomes and molecular determinants of responseCaitlin Murphy, Andrea Muscat, David Ashley, et al.
Journal of Translational Medicine|March 19, 2017
Veliparib in combination with radiotherapy for the treatment of MGMT unmethylated glioblastomaToni Rose Jue, Kyoko Nozue, Ashleigh J Lester, et al.
Journal of Medical Imaging and Radiation Oncology|January 25, 2019
Influence of molecular classification in anaplastic glioma for determining outcome and future approach to managementMichael Back, Dasantha T Jayamanne, David Brazier, et al.
BMJ Open|March 20, 2014
Machine-learning prediction of cancer survival: a retrospective study using electronic administrative records and a cancer registrySunil Gupta, Truyen Tran, Wei Luo, et al.
Frontiers in Oncology|December 24, 2021
Comparative Efficacy of Systemic Agents for Brain Metastases From Non-Small-Cell Lung Cancer With an EGFR Mutation/ALK Rearrangement: A Systematic Review and Network Meta-AnalysisShervin Taslimi, Karanbir Brar, Yosef Ellenbogen, et al.
NPJ Breast Cancer|March 30, 2023
Durable responses in patients with HER2+ breast cancer and leptomeningeal metastases treated with trastuzumab deruxtecanLaura Alder, Dario Trapani, Claire Bradbury, et al.
Cancer|November 21, 2012
Risk of metachronous breast cancer after BRCA mutation-associated ovarian cancerSusan M Domchek, Komal Jhaveri, Sujata Patil, et al.
World Neurosurgery|October 24, 2021
Comparative Efficacy of Treatments for Brain Metastases from Non-Small Cell Lung Cancer without an EGFR-Mutation/ALK-Rearrangement: A Systematic Review and Network Meta-AnalysisKaranbir Brar, Shervin Taslimi, Yosef Ellenbogen, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
BRCA1-A and LIG4 complexes mediate ecDNA biogenesis and cancer drug resistanceOliver W Chung, Shun Yao, Fu Yang, et al.
JMIR Research Protocols|December 4, 2019
Defining the Supportive Care Needs and Psychological Morbidity of Patients With Functioning Versus Nonfunctioning Neuroendocrine Tumors: Protocol for a Phase 1 Trial of a Nurse-Led Online and Phone-Based InterventionLisa Guccione, Karla Gough, Allison Drosdowsky, et al.
Pageof 18

Showing results (91-100 of 176) with videos related to

Sort By:
Pageof 18
Plos One|February 15, 2019
Tailored NEOadjuvant epirubicin, cyclophosphamide and Nanoparticle Albumin-Bound paclitaxel for breast cancer: The phase II NEONAB trial-Clinical outcomes and molecular determinants of responseCaitlin Murphy, Andrea Muscat, David Ashley, et al.
Journal of Translational Medicine|March 19, 2017
Veliparib in combination with radiotherapy for the treatment of MGMT unmethylated glioblastomaToni Rose Jue, Kyoko Nozue, Ashleigh J Lester, et al.
Journal of Medical Imaging and Radiation Oncology|January 25, 2019
Influence of molecular classification in anaplastic glioma for determining outcome and future approach to managementMichael Back, Dasantha T Jayamanne, David Brazier, et al.
BMJ Open|March 20, 2014
Machine-learning prediction of cancer survival: a retrospective study using electronic administrative records and a cancer registrySunil Gupta, Truyen Tran, Wei Luo, et al.
Frontiers in Oncology|December 24, 2021
Comparative Efficacy of Systemic Agents for Brain Metastases From Non-Small-Cell Lung Cancer With an EGFR Mutation/ALK Rearrangement: A Systematic Review and Network Meta-AnalysisShervin Taslimi, Karanbir Brar, Yosef Ellenbogen, et al.
NPJ Breast Cancer|March 30, 2023
Durable responses in patients with HER2+ breast cancer and leptomeningeal metastases treated with trastuzumab deruxtecanLaura Alder, Dario Trapani, Claire Bradbury, et al.
Cancer|November 21, 2012
Risk of metachronous breast cancer after BRCA mutation-associated ovarian cancerSusan M Domchek, Komal Jhaveri, Sujata Patil, et al.
World Neurosurgery|October 24, 2021
Comparative Efficacy of Treatments for Brain Metastases from Non-Small Cell Lung Cancer without an EGFR-Mutation/ALK-Rearrangement: A Systematic Review and Network Meta-AnalysisKaranbir Brar, Shervin Taslimi, Yosef Ellenbogen, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
BRCA1-A and LIG4 complexes mediate ecDNA biogenesis and cancer drug resistanceOliver W Chung, Shun Yao, Fu Yang, et al.
JMIR Research Protocols|December 4, 2019
Defining the Supportive Care Needs and Psychological Morbidity of Patients With Functioning Versus Nonfunctioning Neuroendocrine Tumors: Protocol for a Phase 1 Trial of a Nurse-Led Online and Phone-Based InterventionLisa Guccione, Karla Gough, Allison Drosdowsky, et al.
Pageof 18